{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:35:04Z","timestamp":1780482904891,"version":"3.54.1"},"reference-count":26,"publisher":"e-Century Publishing Corporation","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/mfpv8667","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T23:56:06Z","timestamp":1751241366000},"page":"4516-4523","source":"Crossref","is-referenced-by-count":1,"title":["Alendronate sodium demonstrates significant clinical advantages in treating osteoporosis secondary to severe fractures"],"prefix":"10.62347","volume":"17","author":[{"given":"Shenggen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Bilge O, Dundar ZD, Atilgan N, Yaka H, Kekec AF, Karaguven D and Doral MN. The epidemiology of adult fractures according to the AO\/OTA fracture classification. Ulus Travma Acil Cerrahi Derg 2022; 28: 209-216."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jot.2024.03.002","article-title":"Global, regional, national trends of femur fracture and machine learning prediction: comprehensive findings and questions from global burden of disease 1990-2019","volume":"46","author":"Wu","year":"2024","unstructured":"Wu J, Che Y, Zhang Y, Wang J, Chen M, Jiang J, Jiang Q and Zhou Y. Global, regional, national trends of femur fracture and machine learning prediction: comprehensive findings and questions from global burden of disease 1990-2019. J Orthop Translat 2024; 46: 46-52.","journal-title":"J Orthop Translat"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/brainsci12081056","article-title":"Chronic pain after bone fracture: current insights into molecular mechanisms and therapeutic strategies","volume":"12","author":"Zhao","year":"2022","unstructured":"Zhao Y, Zhang H, Li N, Li J and Zhang L. Chronic pain after bone fracture: current insights into molecular mechanisms and therapeutic strategies. Brain Sci 2022; 12: 1056.","journal-title":"Brain Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/diseases11010045","article-title":"Acute traumatic pain in the emergency department","volume":"11","author":"Zanza","year":"2023","unstructured":"Zanza C, Romenskaya T, Zuliani M, Piccolella F, Bottinelli M, Caputo G, Rocca E, Maconi A, Savioli G and Longhitano Y. Acute traumatic pain in the emergency department. Diseases 2023; 11: 45.","journal-title":"Diseases"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3390\/jcm12031167","article-title":"Does the pathologic fracture predict severe paralysis in patients with metastatic epidural spinal cord compression (MESCC)?-A retrospective, single-center cohort analysis","volume":"12","author":"Klein","year":"2023","unstructured":"Klein L, Herget GW, Ihorst G, Lang G, Schmal H and Hubbe U. Does the pathologic fracture predict severe paralysis in patients with metastatic epidural spinal cord compression (MESCC)?-A retrospective, single-center cohort analysis. J Clin Med 2023; 12: 1167.","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Amarnath SS, Kumar V and Das SL. Classification of osteoporosis. Indian J Orthop 2023; 57 Suppl 1: 49-54.","DOI":"10.1007\/s43465-023-01058-3"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","unstructured":"Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P and Milat F. Secondary osteoporosis. Endocr Rev 2022; 43: 240-313.","journal-title":"Endocr Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11914-022-00717-y","article-title":"Evaluating patients for secondary causes of osteoporosis","volume":"20","author":"Lewiecki","year":"2022","unstructured":"Lewiecki EM. Evaluating patients for secondary causes of osteoporosis. Curr Osteoporos Rep 2022; 20: 1-12.","journal-title":"Curr Osteoporos Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/jcm11092382","article-title":"Secondary osteoporosis and metabolic bone diseases","volume":"11","author":"Sobh","year":"2022","unstructured":"Sobh MM, Abdalbary M, Elnagar S, Nagy E, Elshabrawy N, Abdelsalam M, Asadipooya K and El-Husseini A. Secondary osteoporosis and metabolic bone diseases. J Clin Med 2022; 11: 2382.","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.51507\/j.jams.2022.15.5.281","article-title":"Acupuncture for osteoporosis: a review of its clinical and preclinical studies","volume":"15","author":"Tian","year":"2022","unstructured":"Tian Y, Wang L, Xu T, Li R, Zhu R, Chen B, Zhang H, Xia B, Che Y, Zhao D and Zhang D. Acupuncture for osteoporosis: a review of its clinical and preclinical studies. J Acupunct Meridian Stud 2022; 15: 281-299.","journal-title":"J Acupunct Meridian Stud"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2174\/0113816128310838240820065324","article-title":"Alendronate for effective treatment of male osteoporosis: an insight","volume":"31","author":"Al Lawati","year":"2025","unstructured":"Al Lawati H, Al Busaidi S, Al Rawahi T, Al Lawati A, Kifah A and Das S. Alendronate for effective treatment of male osteoporosis: an insight. Curr Pharm Des 2025; 31: 26-36.","journal-title":"Curr Pharm Des"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00198-023-06863-y","article-title":"Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study","volume":"34","author":"Everts-Graber","year":"2023","unstructured":"Everts-Graber J, Bonel H, Lehmann D, Gahl B, Hauselmann H, Studer U, Ziswiler HR, Reichenbach S and Lehmann T. Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporos Int 2023; 34: 1961-1973.","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11657-024-01480-6","article-title":"Efficacy and safety of weekly liquid alendronate in Korean postmenopausal women with osteoporosis: a 12-month, multi-center, randomized trial","volume":"19","author":"Baek","year":"2024","unstructured":"Baek S, Ahn SH, Hong N, Seo DH, Hong S and Rhee Y. Efficacy and safety of weekly liquid alendronate in Korean postmenopausal women with osteoporosis: a 12-month, multi-center, randomized trial. Arch Osteoporos 2024; 19: 119.","journal-title":"Arch Osteoporos"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S and Cummings SR; Fracture Intervention Trial. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. FIT research group. J Clin Endocrinol Metab 2000; 85: 4118-4124.","DOI":"10.1210\/jcem.85.11.6953"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11657-022-01131-8","article-title":"Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study","volume":"17","author":"Li","year":"2022","unstructured":"Li M, Zhang Z, Xue Q, Li Q, Jin X, Dong J, Cheng Q, You L, Lin H, Tang H, Shen L, Gao X, Hu J, Chao A, Li P, Shi R, Zheng S, Zhang Y, Xiong X, Yu W and Xia W. Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study. Arch Osteoporos 2022; 17: 103.","journal-title":"Arch Osteoporos"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.bone.2015.11.005","article-title":"Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population","volume":"83","author":"Dai","year":"2016","unstructured":"Dai Z, Wang R, Ang LW, Yuan JM and Koh WP. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population. Bone 2016; 83: 171-177.","journal-title":"Bone"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1517\/14656566.2010.533170","article-title":"Strontium ranelate: a look back at its use for osteoporosis","volume":"11","author":"Reginster","year":"2010","unstructured":"Reginster JY and Neuprez A. Strontium ranelate: a look back at its use for osteoporosis. Expert Opin Pharmacother 2010; 11: 2915-2927.","journal-title":"Expert Opin Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/20533691221116769","article-title":"Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: a randomized, placebo-controlled, double-blind trial","volume":"28","author":"Costa-Paiva","year":"2022","unstructured":"Costa-Paiva L, O Wender MC, Machado RB, Pompei LM, Nahas EA, Nahas-Neto J, Del Debbio SY, Badalotti M and Cruz AM. Effects of ultra-low dose hormone therapy on biochemical bone turnover markers in postmenopausal women: a randomized, placebo-controlled, double-blind trial. Post Reprod Health 2022; 28: 149-157.","journal-title":"Post Reprod Health"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00774-003-0438-2","article-title":"Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis","volume":"21","author":"Chailurkit","year":"2003","unstructured":"Chailurkit LO, Jongjaroenprasert W, Rungbunnapun S, Ongphiphadhanakul B, Sae-tung S and Rajatanavin R. Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis. J Bone Miner Metab 2003; 21: 421-427.","journal-title":"J Bone Miner Metab"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1422062","DOI":"10.3389\/fphar.2024.1422062","article-title":"Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis","volume":"15","author":"Yang","year":"2024","unstructured":"Yang Y, Yang M, Su X and Xie F. Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis. Front Pharmacol 2024; 15: 1422062.","journal-title":"Front Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5069918","DOI":"10.1155\/2022\/5069918","article-title":"Effects of pamidronate disodium combined with calcium on BMD values and severity of pain in elderly patients with osteoporosis based on mobile terminal platform for internet of things","volume":"2022","author":"Bai","year":"2022","unstructured":"Bai Z, Wang J, Kang M, Guo P and Wang D. Effects of pamidronate disodium combined with calcium on BMD values and severity of pain in elderly patients with osteoporosis based on mobile terminal platform for internet of things. Dis Markers 2022; 2022: 5069918.","journal-title":"Dis Markers"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00198-024-07268-1","article-title":"Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis","volume":"36","author":"Adesina","year":"2025","unstructured":"Adesina OO, Jenkins IC, Galvao F, de Moura AC, Fertrin KY, Zemel BS and Saad STO. Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis. Osteoporos Int 2025; 36: 93-102.","journal-title":"Osteoporos Int"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.12998\/wjcc.v10.i21.7324","article-title":"Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence","volume":"10","author":"Wang","year":"2022","unstructured":"Wang KM, Wei SP, Yin XY, Meng QJ and Kong YM. Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence. World J Clin Cases 2022; 10: 7324-7332.","journal-title":"World J Clin Cases"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"102922","DOI":"10.1016\/j.redox.2023.102922","article-title":"Tobacco toxins induce osteoporosis through ferroptosis","volume":"67","author":"Jing","year":"2023","unstructured":"Jing Z, Li Y, Zhang H, Chen T, Yu J, Xu X, Zou Y, Wang X, Xiang K, Gong X, He P, Fu Y, Ren M, Ji P and Yang S. Tobacco toxins induce osteoporosis through ferroptosis. Redox Biol 2023; 67: 102922.","journal-title":"Redox Biol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12891-024-07560-5","article-title":"Bone metabolism factors in predicting the risk of osteoporosis fracture in the elderly","volume":"25","author":"Zhang","year":"2024","unstructured":"Zhang J, Hu Y and Cai W. Bone metabolism factors in predicting the risk of osteoporosis fracture in the elderly. BMC Musculoskelet Disord 2024; 25: 442.","journal-title":"BMC Musculoskelet Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3390\/healthcare11131846","article-title":"Osteonecrosis related to steroid and alcohol use-an update on pathogenesis","volume":"11","author":"Konarski","year":"2023","unstructured":"Konarski W, Pobozy T, Konarska K, Sliwczynski A, Kotela I, Hordowicz M and Krakowiak J. Osteonecrosis related to steroid and alcohol use-an update on pathogenesis. Healthcare (Basel) 2023; 11: 1846.","journal-title":"Healthcare (Basel)"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/6\/ajtr0163869.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:57:39Z","timestamp":1766023059000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/6\/ajtr0163869.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/mfpv8667","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}